This Agreement is between Bloody Good Tests Pty Ltd (ABN 62 667 990 963) of 16 Nexus Way, Southport QLD 4215, trading as Eirly Health (Eirly, we, us and our), and the organisation or practitioner that accepts it (the Customer, also you).
If your organisation uses Eirly under an earlier agreement it accepted in the Platform, this Agreement applies to it from the date in our notice to you, or earlier if an Owner accepts it (clause 2.2(b)). If your organisation has a signed agreement with us, that agreement continues on its own terms (clause 2.2(c)).
1. Definitions and interpretation
1.1 Definitions. In this Agreement:
Adjustments has the meaning in clause 19.
API means the Eirly application programming interface that allows the Customer to access and integrate Diagnostic Services into its own offerings.
API Data means Eirly's own catalogue, pricing, reference and operational content transmitted through the API or made available in the Platform, including Product and panel definitions, Order Prices, provider and collection-point mappings, booking, scheduling, availability, location and routing data, reference information, and telemetry about use of the API.
API Data does not include a Result, or any data about an identified or reasonably identifiable Customers' End User, including the structured, normalised or enriched form of a Result. Anything Eirly adds to a Result travels with that Result.
Business Day means a day other than a Saturday, Sunday or public holiday on which banks are open for general business in Brisbane.
Buy For and Send To have the meanings in clauses 9.2 and 9.3.
Channel Customer means, in respect of a request for a Diagnostic Service, a Customer that offers that Diagnostic Service to Customers' End Users but does not make the request through its own Ordering Practitioner, and for which Eirly provides the clinical governance and practitioner ordering layer. See clause 5.1 for how the type is determined and why it matters.
Claim means any claim, demand, remedy, suit, injury, damage, loss, cost, liability, action or proceeding, however arising and whether ascertained or unascertained, immediate, future or contingent.
Commencement Date means the date this Agreement first applies to the Customer under clause 2.2.
Confidential Information means information relating to the business, affairs, technology, customers or suppliers of either party, including the terms of this Agreement, technical data, know-how and API Data, but excluding information that is: (a) already known to the other party free of any duty of confidence and not derived from the disclosing party; (b) received from a third party not under a duty of confidence; (c) independently developed by the other party; or (d) in the public domain other than through breach of this Agreement.
Consumer Terms means Eirly's Consumer Terms published at eirly.health/legal/consumer-terms, as updated from time to time, which govern an individual ordering or paying for a Diagnostic Service for themselves.
Customer (also you) means the organisation or individual practitioner that accepts this Agreement in the Platform, by signing it, or by signing an Order Form. Where a person accepts on behalf of an entity, the Customer is that entity.
Customers' End Users means individuals who use the Customer's services to access Diagnostic Services facilitated by Eirly.
Diagnostic Provider means a pathology laboratory, diagnostic imaging provider, specimen collection provider (including mobile or at-home collection providers using their own scheduling or logistics systems), or other third party that performs, or provides services necessary to fulfil, a Diagnostic Service. Diagnostic Providers may change from time to time.
Diagnostic Services means pathology, diagnostic imaging, and other diagnostic services that Eirly facilitates from time to time, provided by Diagnostic Providers under Eirly's arrangements with them and facilitated through the Platform.
DPA means Eirly's standard Data Processing Agreement published at eirly.health/legal/data-processing-agreement, in the version that applies to the Customer under clause 23.6, or, for the Services under an Order Form that annexes a data processing agreement, that agreement. The DPA forms part of this Agreement for every Customer and needs no separate signature; Eirly will countersign a copy on request. A data processing agreement signed before this Agreement first applied to the Customer stays in force for its Order Form until the parties replace it in writing.
Eirly (also we, us, our) means Bloody Good Tests Pty Ltd (ABN 62 667 990 963) of 16 Nexus Way, Southport QLD 4215, Australia, trading as Eirly Health, the party contracting with the Customer under this Agreement.
Fees means all amounts payable by the Customer for the Services, being: (a) the Platform Fee; (b) any Usage Fee; and (c) the Order Price of each Diagnostic Service or product ordered.
Force Majeure Event means an event beyond a party's control that it could not reasonably have foreseen and that prevents it from performing this Agreement, including natural events, failure of public utilities or communications networks not caused by the affected party or its subcontractors, civil disturbance, acts of authorities, national emergencies, war, strikes, embargoes, cyber attacks beyond the reasonable control of the affected party, and an outage or failure of a Diagnostic Provider, courier, payment processor or hosting provider that the affected party could not reasonably have avoided, but excluding: (a) a data breach caused by the affected party's failure to take reasonable security steps; (b) lack of funds; (c) price rises; and (d) other ordinarily foreseeable events. An event is a Force Majeure Event only to the extent the affected party has taken reasonable steps to prevent or mitigate it (for example, through back-up power and redundancy).
Free Plan means the Plan shown in the Price List as Free, for which no Platform Fee is charged.
Health Practitioner Regulation National Law means: (a) in New South Wales, the Health Practitioner Regulation National Law (NSW); (b) in Queensland, the Health Practitioner Regulation National Law Act 2009 (Qld); (c) in Victoria, the Health Practitioner Regulation National Law (Victoria) Act 2009; (d) in Western Australia, the Health Practitioner Regulation National Law (WA) Act 2010; (e) in South Australia, the Health Practitioner Regulation National Law (South Australia) Act 2010; (f) in Tasmania, the Health Practitioner Regulation National Law (Tasmania) Act 2010; (g) in the Australian Capital Territory, the Health Practitioner Regulation National Law (ACT); (h) in the Northern Territory, the Health Practitioner Regulation National Law (National Uniform Legislation) Act 2010 (NT); as applicable in the jurisdiction where the practitioner practises, and as amended from time to time.
Intellectual Property Rights means patents, utility models, rights to inventions, copyright and neighbouring and related rights, moral rights, trade marks and service marks, business names and domain names, rights in get-up and trade dress, goodwill and the right to sue for passing off or unfair competition, rights in designs, rights in computer software, database rights, and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted renewals or extensions of, or to claim priority from, those rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world.
Laws means any federal, state, municipal or local law, rule, statute, subordinate legislation, regulation, code, guideline, by-law, consent, approval, permit or licence, and any requirement or direction of a government or similar authority binding on the relevant party, as amended. This includes Privacy Law.
Marketplace (or Eirly Marketplace) means the offering operated by Eirly through which Diagnostic Providers supply, and Customers access, Diagnostic Services.
Marks means trade marks, brand names, logos and other brand indicia of either party, including Eirly, Eirly Health, Eirly Marketplace, Bloody Good and Bloody Good Tests, together with their associated logos and devices, in each form a party makes available or notifies the other party from time to time.
Material Change means a variation of this Agreement, or a change to the Services, that does any of the following: reduces the Customer's rights; adds to the Customer's obligations or costs (other than a change to Fees, which follows clause 14.6); changes how Personal Information is handled, by using it for a new purpose, collecting a new kind of Personal Information, or disclosing it to a new kind of recipient (a new Sub-processor follows the DPA); or removes a part of the Services the Customer is using without an equivalent alternative. These are not Material Changes: (a) adding a new product, service or feature, such as a new type of test or imaging, where it does not change the terms of Services the Customer already uses (a new service may come with its own terms, which apply when the Customer chooses to use it); (b) clarifications, corrections, and changes to layout or wording that do not change the meaning; and (c) changes that only add to the Customer's rights or reduce its costs. A Material Change that Law requires Eirly to make sooner may take effect sooner, and Eirly will notify the Customer as soon as practicable. With each new version of this Agreement, Eirly publishes a short summary of what changed, and earlier versions are available on request.
Medical Services means healthcare services provided by an Ordering Practitioner within their scope of practice.
Order Form means a document signed by both parties (an order form or statement of work) that references this Agreement and sets out the Services ordered and any special commercial terms (including negotiated pricing, minimum term, and service levels). A Plan accepted in the Platform is not an Order Form.
Order Price means the price Eirly sets for a Product, as set out in the Price List or the applicable Order Form. An Order Price is made up of whatever components apply to what is ordered, which may include a base price, a collection or shipping charge and, on a Plan that carries one, a service fee, and Eirly sets each of them. The Order Price is the whole of what Eirly charges for that Product. What is charged, including any component shown separately, is displayed in the Platform before the order is placed.
Ordering Practitioner means a person who, for the Diagnostic Service in question: (a) holds the registration, qualification or professional membership that the Law and the Diagnostic Provider require to request it (for example, registration under the Health Practitioner Regulation National Law or, for a test a Diagnostic Provider offers to practitioners outside that law, the qualification or membership that provider accepts), and requests it within their scope of practice; (b) holds the professional indemnity insurance that clause 23.7 requires; and (c) is the Customer or is engaged by it, and requests the Diagnostic Service under their own clinical responsibility.
Owner means a person the Platform records as an owner of the Customer's organisation account.
Personal Information and Sensitive Information have the meanings given in the Privacy Act 1988 (Cth).
Personnel means, in respect of a party, its officers, employees, workers, contractors, agents and subcontractors.
Plan means a subscription plan for the Platform offered in the Price List (for example Free, Practitioner Pro or an API plan), with the plan details shown to an Owner and accepted when the Customer subscribes.
Platform means the Eirly software platform operated by Eirly, including the API and the Marketplace.
Platform Fee means the recurring subscription fee for the Customer's access to the Platform and API, as set out in the Price List for the Customer's Plan or the applicable Order Form.
Practitioner Customer means, in respect of a request for a Diagnostic Service, a Customer that makes that request through an Ordering Practitioner (who may be the Customer itself, where the Customer is an individual practitioner), under that practitioner's clinical responsibility. A Customer with no Ordering Practitioner for a request cannot be a Practitioner Customer for it. See clause 5.1.
Price List means Eirly's price list available in the Platform when the Customer is signed in, and on request, or set out in the applicable Order Form, as updated from time to time in accordance with clause 14.6. The Price List sets out the Platform Fee, any Usage Fee and the Order Price of each Product, and, for each Plan, its plan details: the price, the billing period (monthly or annual), any upfront payment option, what a price hold covers, eligibility, and the support arrangements. It may include different pricing and fee models for different Diagnostic Services, Products, panels, billing types (including Medicare-billed items) and channels.
Privacy Law means all federal, local or other applicable laws or regulations of any governmental or regulatory authority governing the handling of information about an identifiable individual, including the Privacy Act 1988 (Cth), the Australian Privacy Principles, and any other Law relating to privacy or the handling of personal information that applies to a party.
Privacy Policy means Eirly's privacy policy published at eirly.health/legal/privacy-policy, as updated from time to time.
Product means one orderable line in an order placed through the Platform, whether a Diagnostic Service, an at-home test kit or another item in the Marketplace. A pathology panel is one Product however many markers it contains; an at-home test kit is one Product; an imaging study is one Product. A Product is not a single test within a panel, and is not the whole order.
Records means Customers' End User data, including Results and relevant medical records, retained by Eirly in connection with the Diagnostic Services.
Refund and Credit Policy means Eirly's refund and credit policy published at eirly.health/legal/refund-and-credit-policy and available in the Platform, as referred to in clause 14.5(b).
Result means, for pathology, one laboratory number and all messages linked to it, however many test items or individual reports that covers. Interim, cumulative and amended reports arising from the same laboratory number are part of the same Result and are not counted again. For any other Diagnostic Service, a Result is the report or findings of that service in relation to a specimen or examination of a Customers' End User. Results has the corresponding meaning.
Services means the services Eirly provides as described in clauses 3 to 5, accessed through the Platform and API.
Significant Result means a Result that the Diagnostic Provider reports as critical by contacting Eirly or the Ordering Practitioner directly. An abnormal or out-of-range Result is not by itself a Significant Result.
Special Conditions means any special terms set out in an Order Form.
Supply-Side Partner means a Diagnostic Provider or other party that supplies Diagnostic Services, or related goods or services, through the Marketplace.
Terms of Use means Eirly's Terms of Use published at eirly.health/legal/terms-of-use, as updated from time to time, accepted by every individual user at their own sign-up and referred to in clause 2.5.
Usage Fee means a fee for the use of a feature or data service, charged in addition to the Platform Fee, including a fee for each Result delivered into the Platform, as set out in the Price List or the applicable Order Form.
1.2 Interpretation. Headings do not affect interpretation. The singular includes the plural; a reference to a person includes a body corporate; "includes" means "includes without limitation"; a reference to a document includes that document as amended; a reference to legislation includes subordinate and amending legislation; and all $ references are to Australian dollars unless stated otherwise. Capitalised terms not defined here have the meaning given in the applicable Order Form or the DPA.
2. Structure of the Agreement
2.1 Framework. This Agreement is a framework. It governs your access to and use of the Services. The specific Services, pricing and any special commercial terms are set out in an Order Form or, for standard self-serve access, in the Plan accepted in the Platform and the Price List.
2.2 Acceptance. The Customer accepts this Agreement when an Owner ticks the box in the Platform that names it (on creating the organisation, on subscribing to a Plan, or on moving to a new version), or by signing this Agreement or an Order Form. Eirly is not bound until it accepts the sign-up or signature, which it may decline at its discretion.
(a) Acceptance record. Eirly records each acceptance: the organisation, the person, the time, the text accepted (by its effective date) and a fingerprint of that text. Eirly makes the record available to the Customer in the Platform. Where the Customer signs this Agreement or an Order Form, the signed document is the record. Eirly will provide a copy of any version of this Agreement or the Price List on request.
(b) Moving from an earlier agreement accepted in the Platform. Where the Customer was using the Services under an earlier agreement with Eirly that it accepted in the Platform (including the Bloody Good Tests Service Provider Agreement and any API agreement), this Agreement applies from the earlier of: the date an Owner accepts it; and the date the earlier agreement ends under Eirly's notice, if the Customer continues to use the Services after that date. From that date this Agreement replaces the earlier agreement. Amounts accrued and orders placed under the earlier agreement stay payable and are dealt with under this Agreement.
(c) Signed agreements continue. Where the Customer has signed an Order Form or other agreement with Eirly, that agreement, with the version of this Agreement and the DPA it incorporates, continues on its own terms, including its own terms for variation. Clause 2.2(b) and any general notice of this version do not apply to it, and publishing this version does not vary it.
(d) Price applying to an order. The Price List that applies to a transaction is the Price List in effect when the order is placed (clause 14.6).
(e) Authority. A person who accepts this Agreement on behalf of an entity warrants that they are authorised to bind that entity. By accepting, the Customer acknowledges that it has read and understood this Agreement and agrees to be bound by it.
2.3 Order Forms. Each Order Form is a separate contract incorporating this Agreement. Where terms differ between Order Forms, each applies only to its own Services.
2.4 Order of precedence. If there is an inconsistency, the following order applies (higher prevails): (a) the DPA, but only in respect of the Processing of Personal Information and excluding the limitation of liability, which is governed by clause 22; (b) the Special Conditions in the applicable Order Form; (c) the remaining terms of the applicable Order Form; (d) the plan details accepted for the Customer's Plan; (e) this Agreement; and (f) the Price List and any policies referenced in this Agreement.
An Order Form, including its Special Conditions, varies this Agreement only where it says so and names the clause it varies. It cannot vary the DPA except in the way the DPA allows.
2.5 Relationship with the Terms of Use, Consumer Terms and Privacy Policy. Every individual user, including the Customer's Personnel, accepts the Terms of Use and the Privacy Policy at their own sign-up. An individual who orders or pays for a Diagnostic Service for themselves (including a practitioner doing so on my.eirly.health) does so under the Consumer Terms, not this Agreement. Those documents sit separately from, and continue to apply alongside, this Agreement. This Agreement is the practitioner and business agreement between the parties and governs the Customer's access to and use of the Services; to the extent of any inconsistency in that relationship, this Agreement prevails over the Terms of Use. For the avoidance of doubt: (a) any restriction on competitors in the Terms of Use does not apply to the Customer or its Related Bodies Corporate in connection with this Agreement; and (b) nothing in this Agreement affects the Terms of Use, the Consumer Terms or the Privacy Policy as they apply to, or are accepted by, a Customers' End User or any other individual.
2.6 What this Agreement includes, and entire agreement. This Agreement includes, and the Customer accepts with it: (a) the DPA (eirly.health/legal/data-processing-agreement); (b) the Refund and Credit Policy (eirly.health/legal/refund-and-credit-policy); (c) the plan details accepted for the Customer's Plan, and the Price List; and (d) any Order Form, including its Special Conditions.
The Terms of Use (eirly.health/legal/terms-of-use) and the Privacy Policy (eirly.health/legal/privacy-policy) apply alongside it under clause 2.5. Together these are the entire agreement between the parties in respect of their subject matter and supersede all prior representations, understandings and agreements between them on that subject matter, including any earlier agreement replaced under clause 2.2(b), other than a signed agreement continuing under clause 2.2(c) or any agreement identified as surviving in the applicable Order Form. Nothing in this clause supersedes the Terms of Use, the Consumer Terms or the Privacy Policy, or limits liability for fraud.
2.7 Plans. A Plan binds the Customer when an Owner accepts it in the Platform after being shown its plan details and price. Only an Owner may subscribe to, change or cancel a Plan. A change of Plan or billing option binds only when the new plan details and price are shown and an Owner accepts them; using a feature does not by itself authorise a charge. A paid Plan is billed monthly, or annually in advance where an Owner chooses an annual Plan. Cancelling a Plan is dealt with in clause 20.2A.
2.8 Trials. Eirly may offer a free trial of a Plan for the period shown in the Platform, on the eligibility it sets (in general, one trial for each organisation). During a trial no Platform Fee is charged for that Plan; everything else in this Agreement applies, including Order Prices. At the end of the trial the Customer moves to the Free Plan unless an Owner has accepted the paid Plan and its price. A trial never becomes a paid Plan without that acceptance, and a trial or other free benefit changes nothing else in the Customer's terms.
2.9 The Customer's own paperwork. Terms in the Customer's purchase orders, supplier portals, vendor registration forms or similar documents do not form part of, or vary, this Agreement, even if Eirly completes, accepts or signs them, unless an Order Form signed by both parties says so.
2.10 Owners. The Customer acts through its Owners. An Owner's acceptance binds the Customer, and this Agreement continues when Owners change: a new Owner does not need to accept it again, and an Owner who leaves does not take it with them. The Customer is responsible for choosing its Owners and other users, for promptly removing anyone who should no longer act for it, and for keeping at least one current Owner with a working email address (clause 17.1). Eirly may rely on the Platform's record of who is an Owner. Where people disagree about who controls the Customer's account, Eirly may ask for reasonable evidence of authority and may limit changes to the account until the disagreement is resolved, without having to decide it.
3. Nature of the Services and Diagnostic Services
3.1 The Marketplace. Eirly operates the Eirly Marketplace, through which Customers can order Diagnostic Services supplied by Diagnostic Providers. The Services comprise providing the Platform and API and facilitating access to Diagnostic Services. Eirly's role varies with the arrangement and may range from providing the Platform and facilitating a transaction between a Customer and a Diagnostic Provider, to acting as the ordering and clinical-governance layer, as set out in this Agreement and the applicable Order Form. In all cases, Eirly does not itself perform the Diagnostic Services, which are performed by the Diagnostic Provider.
3.2 Diagnostic Providers. Diagnostic Services are provided by Diagnostic Providers. Eirly may change, modify or discontinue any aspect of the Diagnostic Services, including the Diagnostic Providers used, with reasonable prior notice where the change will impact the Customer. That notice requirement does not apply where a Diagnostic Provider or other vendor withdraws, discontinues or ceases to supply a product or service, in which case Eirly may remove it from the Platform immediately, will notify the Customer as soon as practicable, and will use reasonable efforts to identify an equivalent alternative.
3.3 Third-party arrangements. Eirly is not a party to any agreement between the Customer and its Customers' End Users, or between the Customer and any Diagnostic Provider, except as set out in clause 9 (where Eirly contracts with and collects from an individual on a Send To order) and clause 5 (where Eirly is the ordering party).
3.4 Eirly's role differs by Diagnostic Service. Eirly holds the arrangements with the pathology laboratories and other Diagnostic Providers in Australia through which Diagnostic Services are provided. For some Diagnostic Services Eirly is the vendor to the Customer, holds a wholesale arrangement with the Diagnostic Provider, and carries the clinical governance role described in clause 5. For others Eirly is the marketplace and software provider only: the Diagnostic Provider or Supply-Side Partner is the service provider, is responsible for performing and supporting the service, and Eirly supplies the catalogue, ordering workflow, integration and payment handling. The Price List or the applicable Order Form identifies which applies to a Diagnostic Service. Eirly's Fees are charged for the Platform, the integration and the data services it performs, in each case as set out in clause 14.
3.5 Facilitator arrangements. Where Eirly acts as facilitator or intermediary for a Diagnostic Service, the Diagnostic Provider is responsible for performing and supporting that Diagnostic Service, including service delivery, clinical responsibility, and handling complaints about it, and Eirly may direct the Customer or a Customers' End User to the Diagnostic Provider for those matters. Eirly remains responsible for the booking, connection and coordination functions it performs, for which the applicable Fees apply.
3.6 Patients under 18. No one under 18 may hold an account. Only an Ordering Practitioner may request a Diagnostic Service for a patient under 18, under that practitioner's clinical responsibility.
4. Access and use
4.1 Licence. In consideration of the Fees, Eirly grants the Customer a non-exclusive, non-transferable, revocable licence to access and use the Platform, the API and the API Data solely to integrate, price, offer and fulfil the Diagnostic Services and Products within the Customer's own service offerings, including offering them to its own Customers' End Users. Clause 4.6 applies to any other use of API Data.
4.2 Instructions. The Customer must comply with Eirly's reasonable instructions and guidelines for use of the Platform and API.
4.3 Restrictions. The Customer must not: (a) modify, interfere with, reverse engineer, decompile or disassemble the Platform or API, or copy Eirly's Intellectual Property Rights, except as permitted by the Copyright Act 1968 (Cth) or other applicable Laws; (b) seek to derive source code from the API, or permit another person to do so; (c) publicly disseminate performance information about the API; (d) sublicense, resell or make the API available to a third party, except under a reseller or other written agreement signed by Eirly that permits it; (e) use the Platform or API in a manner that could damage, disable or impair the Services; (f) use the Platform or API for any unlawful, misleading or harmful purpose, or in breach of any Law; or (g) introduce any malware, interfere with the security or integrity of the Platform, or exceed any rate or usage limits notified by Eirly; (h) circumvent, or attempt to circumvent, any verification, eligibility, scope or catalogue restriction applied under clause 5.7; (i) represent that it, or any practitioner acting under its account, holds a registration, qualification or scope of practice that it does not hold; (j) represent that Eirly is the treating, referring or requesting practitioner for a Customers' End User, or that Eirly has assumed clinical responsibility, except where Eirly is the ordering party for that request under clause 5.1; or (k) use the Services in a way that could bring Eirly, a Diagnostic Provider or a Supply-Side Partner into disrepute or regulatory jeopardy.
4.4 Suspension. Eirly may suspend the Customer's access to the Platform and API, in whole or in part, immediately and with notice where practicable, if: (a) Eirly reasonably considers it necessary to protect the security, integrity or availability of the Platform or the safety of any individual; (b) the Customer's use is unlawful or unsafe, or breaches this Agreement; (c) a payment remains unresolved after the retry period in clause 14.4; or (d) suspension is required to comply with Eirly's clinical governance framework, a Law, or a request from a regulator, court or law enforcement agency. Eirly will limit any suspension to what is reasonably necessary and restore access once the cause is resolved. Platform Fees do not accrue during a suspension under paragraph (a) or (d), and continue to accrue during a suspension under paragraph (b) or (c). The Customer remains liable for all Fees for orders placed before a suspension.
A suspension restricts the Customer's ability to place new orders and its commercial access; it does not remove access to data already held. Eirly may move an account to read-only access rather than withdraw it. A suspension never affects: delivery of a Result for a specimen already collected; escalation of a Significant Result; or a Customers' End User's access to their own Results. Eirly continues to meet its record-retention, access and clinical obligations throughout.
Where an individual paid directly (Send To) and has charged back or been refunded, Eirly need not deliver the final Result to the Customer or that individual, except that a Result is always released where clinical duty requires it, including any Significant Result, and nothing in this clause limits clause 5. Where the individual proceeds with the Diagnostic Service after a chargeback or refund, Eirly may re-charge the amount, and the Customer remains liable for it.
4.5 Group, third parties and anti-avoidance. The Customer must ensure that each of its Related Bodies Corporate and Personnel, and every other person the Customer engages, authorises or permits (including any software developer, integrator, agency or service provider, whether or not related to the Customer), that accesses, uses, operates, or builds or maintains an integration with the Platform or API, or benefits from the Services, complies with this Agreement as if it were the Customer. The Customer is liable for the acts and omissions of each such person as if they were its own, must have arrangements in place with each of them sufficient to ensure that compliance, and must not do indirectly, or permit any person to do, anything it is prohibited from doing directly. An Order Form may name such persons; a person is bound under this clause whether or not it is named.
4.6 No systematic extraction or replication. The Customer must not, and must not permit any person to: (a) access or extract data from the Platform or API by automated or systematic means, or in bulk, other than as reasonably necessary to fulfil actual Customers' End User orders; or (b) use Eirly's Confidential Information, including API Data, to build, train or operate a pathology or diagnostic ordering, integration or results platform or API that competes with the Platform's integration services, such as a service that connects other businesses to Diagnostic Providers. Building and running the Customer's own marketplace, practitioner portal, patient app or clinical product on the Services is not competing. For the avoidance of doubt, and consistently with clause 4.7, nothing in this clause restricts the Customer from dealing with any Diagnostic Provider directly, or from developing, procuring, operating or migrating to its own or a third party's diagnostic ordering capability, provided it does so without using Eirly's Confidential Information and without reverse engineering the API. Eirly may apply reasonable rate or volume limits. Use of the Platform and API in the ordinary course to place and fulfil actual Customers' End User orders, including reasonable caching and synchronisation for that purpose and normal high-volume use within any applicable rate or volume limit, is not a breach of this clause.
4.7 Provider relationships. The Customer may hold or enter into its own arrangements with Diagnostic Providers, and nothing in this Agreement restricts it from dealing with any Diagnostic Provider directly. Where the Customer uses the Platform to facilitate orders under such an arrangement, the Services and applicable Fees apply.
4.8 Deployment surfaces. Where the Customer makes the Services or Diagnostic Services available to Customers' End Users through any website, application, marketplace or platform, including one operated by a Related Body Corporate or a third party, the Customer must identify those surfaces (in the Order Form where Eirly requires) and ensure each complies with this Agreement. The Customer remains responsible and liable for all such surfaces, and for all use of the Services through them, as if it were the Customer's own use.
4.9 Authorised users and delegation. Each individual who accesses the Platform must use their own credentials, and credentials must not be shared. The Customer is responsible for all activity under its accounts, and all access and actions are recorded in an audit trail. A practitioner may authorise a member of its team to place orders, or to apply the practitioner's signature to a referral, on the practitioner's behalf, but only where the practitioner has genuinely authorised it and remains clinically and legally responsible for the order and the referral. Delegated ordering and delegated signature application are lawful and common in clinical practice, but only where the practitioner has expressly authorised the delegate. The Customer warrants that each such authorisation is express, documented, valid and current, that the practitioner made the clinical decision for each request, and that the arrangement complies with all applicable Laws including any requirement of the Health Insurance Act 1973 (Cth) for a Medicare-billed request. Eirly relies on that warranty, does not verify it, and records who performed each action. A failure of authorisation is the Customer's breach of this clause. Eirly may refuse or remove any individual's access, including someone the Customer has invited, where it reasonably suspects misuse or a breach of clause 4.3, 4.6 or 24.
4.10 Staging and test environments. Eirly may give the Customer access to a staging or test environment (for example, addresses under staging.eirly.health) to build and test an integration. It is provided free and as is, for testing only: (a) the Customer must use only test or made-up data in it, never real patient or Customers' End User information; (b) no Diagnostic Service is performed in it, and nothing in it is a real Result; (c) Eirly may reset it, delete its data, or change or withdraw it at any time; and (d) clause 16 does not apply to it. Everything else in this Agreement applies to its use, including clauses 4.3, 4.6, 11 and 24. An organisation in the test environment is separate from one in production, which accepts this Agreement when it is created.
4.11 Integrations Eirly provides. Eirly may offer integrations, apps and connectors that link the Platform with third-party services the Customer uses, such as an online store or a practice management system, and may add to, change or retire them over time. Eirly gives at least 30 days' notice before retiring an integration the Customer is using, unless the third party withdraws or changes its service sooner. Eirly takes reasonable care to keep each integration working and the data it passes accurate. Eirly does not control the third party's service, and the Customer uses it under that party's own terms. Connecting an integration authorises Eirly to exchange with that service the data the integration needs, including Results and other health information where the integration carries them. A third-party service the Customer connects is the Customer's choice and is not Eirly's Sub-processor under the DPA, and once data reaches that service, the Customer and that service's provider are responsible for it there. The Customer is responsible for its settings in that service and for checking that what it shows there, such as patient records, product details and prices, is correct. Eirly remains responsible for its own integration software as part of the Platform.
5. Diagnostic Services and clinical responsibility
5.1 Who is clinically responsible, and how that is decided. Eirly facilitates the provision of Diagnostic Services in accordance with its arrangements with Diagnostic Providers. Eirly does not itself perform Diagnostic Services.
Every request for a Diagnostic Service is either a Practitioner Customer request or a Channel Customer request. The test is one question: who made the request?
| Who made the request | Type for that request | Who is clinically responsible |
|---|---|---|
| An Ordering Practitioner of the Customer (who may be the Customer itself) | Practitioner Customer | That Ordering Practitioner, see clause 5.3 |
| Eirly, through its clinical governance and practitioner ordering layer | Channel Customer | Eirly, see clause 5.6 |
Only an Ordering Practitioner can make a Practitioner Customer request. Eirly may limit what the Customer can order under clause 5.7. Where the Customer has no Ordering Practitioner for a request, the request can only be made by Eirly, if Eirly accepts the order, and it is a Channel Customer request.
Why this matters. The type decides who must counsel the individual before the test, who must receive and act on a Significant Result, and whose clinical judgement prevails if Eirly's clinical governance framework and the Customer's instruction differ (clause 5.5). It is not a description of the Customer's business: it turns only on who raised the request.
The same Customer will often be both. A Customer may be a Practitioner Customer for some requests and a Channel Customer for others, including for the same Diagnostic Service on different occasions. Eirly records the applicable type, and the practitioner holding clinical responsibility, against each request in the Platform, and that record is determinative between the parties.
5.2 Customer compliance. The Customer must ensure its offering of Diagnostic Services complies with all applicable Laws.
5.3 Practitioner Customer duties. Where the Customer is a Practitioner Customer, the Customer must itself, or must ensure that its Ordering Practitioner does, each of the following: (a) before a Diagnostic Service is requested, counsel the Customers' End User about the clinical utility, relevance and implications of the test or examination in accordance with clinical standards; (b) be available to receive Results in a timely manner and promptly review, interpret and clinically manage them; (c) in respect of a Result that the Diagnostic Provider reports as critical by contacting Eirly or the Ordering Practitioner directly (a Significant Result): be contactable to receive it promptly; contact the Customers' End User as soon as practicable; and counsel and advise them on managing the result. An abnormal or out-of-range Result is not by itself a Significant Result, and is managed under paragraph (b); and (d) ensure Customers' End Users are informed about the Diagnostic Services and that necessary consent is obtained before a Diagnostic Service is requested.
5.4 Clinical responsibility. A Practitioner Customer acknowledges that it, or its Ordering Practitioner, is solely responsible for all clinical interactions with Customers' End Users, including counselling, result interpretation and clinical management. Eirly's role is limited to facilitating the Diagnostic Services and delivering Results, subject to Eirly's own clinical governance framework. The Customer must notify Eirly immediately if it becomes unable to meet these obligations, including on any change to its own or an Ordering Practitioner's registration status.
5.5 Eirly's clinical governance. Eirly operates a clinical governance framework. Acting reasonably and in accordance with that framework and applicable clinical standards: (a) where Eirly is the ordering party for a Diagnostic Service, including where clause 5.6 applies, Eirly may flag, withhold, delay, escalate or require practitioner review of a Result, for no longer than is reasonably necessary for that review, and any such decision overrides an inconsistent instruction from the Customer; (b) where the Customer or its Ordering Practitioner requested the Diagnostic Service, Eirly may flag a Result, escalate it to that Ordering Practitioner, and delay its release to the Customers' End User pending that escalation, will escalate a Significant Result to that Ordering Practitioner as soon as practicable, and will not withhold the Result from the Ordering Practitioner responsible for that Customers' End User except where required by Law or by a binding order. Where a Diagnostic Provider reports a Significant Result to Eirly, Eirly's doctor also follows it up, including by contacting the Customers' End User, unless the Customer has a doctor on its team and has asked to follow up Significant Results itself; in that case Eirly passes the Result to that doctor and contacts the Customers' End User only if it cannot reach them in time or the Law requires it; and
(c) Withholding release to the individual. Where the Platform offers the Customer or its Ordering Practitioner the option to withhold a Result from a Customers' End User pending the practitioner's review, the practitioner decides when to release it, and there is no time limit. Withholding never stops Eirly following up a Significant Result under its clinical governance framework, including by contacting the Customers' End User.
Eirly will notify the Customer promptly where it acts under this clause and this materially affects the Customer. Nothing in this clause reduces the Customer's obligations under clause 5.3, which continue in respect of every Result whether or not Eirly also communicates with the Customers' End User.
5.6 Ordering responsibility. The Customer must ensure that each request for a Diagnostic Service is made or supervised by a person qualified to request it under applicable Laws. Where the Customer is a Channel Customer for a request (see clause 5.1), Eirly's clinical governance framework, including its own practitioner review and referral processes, applies to that Diagnostic Service, and the Customer must not represent to any person that the Customer provides that clinical service.
5.7 Scope of practice, and what the catalogue does not mean. The Customer is solely responsible for determining whether a request for a Diagnostic Service is within its own or its Ordering Practitioner's scope of practice, registration and professional obligations. The availability of a Diagnostic Service or Product in the catalogue, or the Platform accepting an order for it, is not a representation by Eirly that the order is within that scope, or that the Customer or its practitioner is eligible to order it. Eirly's acceptance of an order is not an endorsement of its clinical appropriateness.
Eirly may restrict the Diagnostic Services and Products available to a Customer by reference to the registration, profession, scope of practice or verification status of the Customer and its Ordering Practitioners, and may change those restrictions on reasonable notice.
6. Warranties and covenants
6.1 Practitioner registration. Where the Customer is a Practitioner Customer, it warrants that it, or each Ordering Practitioner through which it requests a Diagnostic Service, holds all current qualifications, registrations and accreditations required to request that Diagnostic Service and to provide the associated Medical Services, holds the insurance clause 23.7 requires, and is in good standing with AHPRA or the professional body concerned.
6.2 Licences and authorisations. Each party warrants that it has all licences and authorisations required by Law for it to operate its business and perform its obligations under this Agreement. The Customer warrants that it will only request Diagnostic Services for individuals under its care or under the care of its Ordering Practitioner, and in accordance with applicable standards.
6.3 Use of the Platform. The Customer will use the Platform and API only in accordance with this Agreement and applicable Law.
6.4 No other warranties. The Platform and API are provided "as is". To the extent permitted by Law, Eirly gives no warranties, express or implied, regarding the Platform, API, or any information sent to or from them, and disclaims all implied warranties including merchantability, fitness for purpose and non-infringement. Nothing in this clause excludes rights that cannot be excluded under the Australian Consumer Law.
6.5 Territory. The Services are provided for the ordering and delivery of Diagnostic Services in Australia. The Customer is responsible for complying with the Laws of any jurisdiction in which it operates or from which it accesses the Services, and Eirly makes no representation that the Services are suitable or lawful for use outside Australia. Eirly is not liable for the Customer's use of the Services in, or for Customers' End Users located in, a jurisdiction outside Australia.
6.6 Provider credentials and Medicare. The Customer warrants that any practitioner, provider number, or credential it (or a person acting under its account) submits or uses through the Platform is genuine, current, and used by or with the authority of the person to whom it belongs, and that, so far as the Customer is aware, each order is lawfully made. The Customer is responsible for verifying the identity and eligibility of the practitioners and providers who order through it, and for maintaining their registration and any required insurance.
Eirly's verification. Eirly verifies the registration status of each practitioner it credentials against the relevant public register maintained under the Health Practitioner Regulation National Law, at onboarding and at least annually. The Customer must notify Eirly immediately where a practitioner's registration lapses, is suspended or cancelled, or becomes subject to a condition, undertaking or reprimand. Eirly may prevent new orders, suspend under clause 4.4, or terminate under clause 20.3 where a registration lapses, is restricted, or cannot be verified.
Practitioner consent. Before any request is made through the Platform under a practitioner's name or provider number, including a Medicare-billed request, the Customer must have that practitioner's written agreement to: (a) the use of their name and provider number on the Platform for the Customer's requests; and (b) the delivery of Results requested under that provider number to the Customer's account in the Platform. The Customer must keep that agreement for as long as requests are made under it and for 7 years after, and must give a copy to Eirly, or to a Diagnostic Provider that asks, on request. Eirly may pause requests under a provider number until that agreement is provided. The Customer must tell Eirly promptly if a practitioner withdraws that agreement or leaves the Customer, or if their registration or provider number is cancelled, suspended or changed, and must stop making requests under it.
Eirly's verification does not reduce the Customer's warranties or responsibility under this clause. Eirly relies on those warranties and is not liable for any loss arising from a false, invalid, or unauthorised credential or provider number, or from an order that is fraudulent or unlawful, beyond the verification it performs under this clause. Eirly may suspend under clause 4.4, or terminate under clause 20.3, where it reasonably suspects fraud or misuse.
7. Consent and data protection
7.1 Consents and notices. The Customer must: (a) obtain all consents required from Customers' End Users for the collection, use and disclosure of their Personal Information and Sensitive Information, including for sharing with Eirly and Diagnostic Providers; (b) ensure its privacy policy and terms adequately disclose that sharing; and (c) provide clear privacy notices explaining how data will be used and shared.
7.2 Privacy compliance. Each party must handle the Personal Information it collects or receives in connection with this Agreement in accordance with Privacy Law and the DPA.
7.3 DPA. The DPA governs the Processing of Personal Information and prevails over this clause 7 to the extent of any inconsistency.
7.4 Safeguards. Given the sensitive nature of health data, both parties will implement appropriate safeguards, including encryption in transit and at rest, and prompt notification of data breaches. Neither party will request Personal Information beyond what is reasonably necessary to provide the Services. Any ambiguity in this Agreement is to be interpreted to permit compliance with Privacy Law. For certainty, each party will use Personal Information only to provide or receive the Services, as otherwise permitted by this Agreement (including clauses 5, 8 and 20.5) and the DPA (including DPA clause 2.3), or as required or authorised by Law. Each party remains responsible for its own obligations under Laws, and liability between the parties is governed by clause 22.
8. Customers' End User data and accounts
8.1 Records and accounts. Eirly creates and maintains a patient record for each Customers' End User from the information the Customer provides, as necessary to receive, match and deliver Results. An account, a credentialed login to the Platform, is created only where the Customers' End User completes sign-up and accepts the Terms of Use. Where the Customer uses the API, no account is created unless the Customer elects otherwise.
8.2 Handling End User data. Eirly will handle Customers' End User data in accordance with Privacy Law, this Agreement and the DPA. Where Eirly handles that data on the Customer's behalf, it does so on the Customer's documented instructions under DPA clause 2.2. Where Eirly acts in its own right under DPA clause 2.3, or for an individual's own Eirly account, the Privacy Policy also applies, and Eirly will notify the Customer of any material change to it.
8.3 Retention. Eirly will retain Customers' End User data, including Results and Records, in accordance with applicable Laws and mandated retention periods.
8.4 Access. Eirly will provide the Customer with secure access to Customers' End User data, including Results and Records, through the Platform and API during the term, including the ability to retrieve and export Records and Results. The Customer may independently retain and use copies of Records and Results in accordance with applicable privacy laws, the Customer's privacy policy and the DPA.
8.5 Records after termination. The Customer acknowledges Eirly may need to retain Records after termination to comply with legal obligations.
8.6 Permitted use. Eirly may use Customers' End User data to: (a) provide the Services, and improve them using de-identified data under clause 8.8; (b) generate aggregated, de-identified statistical data; (c) comply with legal obligations; and (d) as otherwise permitted by Privacy Law and, for activities under DPA clause 2.3, the Privacy Policy. Subject to clause 8.8, Eirly will not use the data for any other purpose.
8.7 Individual requests. The Customer is responsible for handling Customers' End Users' requests regarding their Personal Information (access, correction, deletion). Eirly will provide reasonable assistance to the extent it holds the relevant information.
8.8 De-identified data. Eirly may create aggregated and de-identified data from Customers' End User data, de-identified in accordance with Privacy Law so that it is not re-identifiable, and use it to operate, secure, analyse and improve the Services. Eirly may also publish aggregate statistics, such as totals and averages, that do not identify the Customer or any individual (for example, the number of people or tests on the Platform). Eirly will not attempt to re-identify the data, will require anyone it gives it to not to re-identify it, and will not sell, licence or disclose personal or health information about an identifiable individual.
9. Ordering and payment
9.1 Payment options. The Customer may request Diagnostic Services using the "Buy For" or "Send To" options.
9.2 Buy For. The Customer purchases the Diagnostic Service on behalf of the Customers' End User and is responsible for collecting payment from them. Subject to clause 9.5, Eirly emails the Customers' End User to confirm the purchase and provide an account sign-up link. The Customer is responsible for ensuring the Customers' End User completes sign-up.
9.3 Send To. The Customer requests the Diagnostic Service but does not pay upfront. Subject to clause 9.5, Eirly emails the Customers' End User for confirmation, including Eirly's terms and the amount payable, the End User confirms Records may be shared with the Customer, and Eirly collects payment from the End User.
9.4 Informing End Users. The Customer must ensure Customers' End Users are informed about the payment process for each option.
9.5 API integrations. Where the Customer's Plan or Order Form records that the Customer integrates via the API and manages Customers' End User communications itself, Eirly does not send the confirmation or account sign-up emails described in clauses 9.2 and 9.3, and the Customer is responsible for those communications, including informing the Customers' End User of Eirly's terms and, for a Send To order, the amount payable and the sharing of Records with the Customer. Eirly may still send any communication necessary to collect payment from a Customers' End User on a Send To order, to obtain a consent Eirly is required to hold, or to meet a legal or clinical obligation. This clause does not limit clause 5.5, and where Eirly is the ordering party for a Diagnostic Service, Eirly contacts the Customers' End User directly in respect of a Result that requires escalation under Eirly's clinical governance framework.
10. Channel, regulatory and advertising requirements
10.1 Customer offerings. If the Customer offers Diagnostic Services through its website or platform, it must: (a) not allow orders for persons under 18, including orders placed by a parent, carer or guardian, other than a request by an Ordering Practitioner under clause 3.6; (b) display notifications for notifiable diseases as required by Eirly; and (c) obtain any consent required for notification of results to relevant governmental agencies. For clarity, nothing in this Agreement restricts the Customer from offering, through its website or platform, any testing or health services that are not facilitated through the Platform.
10.2 Regulatory and advertising compliance. The Customer is solely responsible for its own marketing, advertising and use of data in connection with the Services, and must comply with all applicable Laws, including the advertising requirements of AHPRA and the Health Practitioner Regulation National Law, and the therapeutic goods advertising provisions, and must not offer any prohibited inducement to request a Diagnostic Service. Eirly's role is limited to supporting and fulfilling the Diagnostic Service order. Eirly is not responsible or liable for how the Customer advertises, markets, or uses the Services or data.
10.3 Names and descriptions. Names, descriptions and other content the Customer creates in the Platform, such as bundle names and descriptions and the business name shown on a card statement, must be accurate, lawful and professional. They must not be offensive or misleading, and must not describe a Diagnostic Service as diagnosing, treating or preventing anything it does not. Eirly may edit or remove content that does not meet this.
11. Intellectual property
11.1 Ownership. This Agreement does not transfer any Intellectual Property Rights to the Customer. As between the parties, Eirly owns all Intellectual Property Rights in the Platform and API. The Customer's only rights to the Platform and API are those temporarily granted under this Agreement. Each party retains ownership of its own pre-existing Intellectual Property Rights. As between the parties and to the extent legally permitted, the Customer retains all right, title and interest in data supplied by or on behalf of the Customer or a Customers' End User, excluding API Data and data aggregated and de-identified under clause 8.8.
11.2 Feedback. Any Intellectual Property Rights in comments, feature requests or other feedback the Customer provides about the Platform or API (Feedback) vest in Eirly on disclosure, and the Customer assigns them to Eirly, to the extent capable of assignment (including under s 197 of the Copyright Act 1968 (Cth)). The Customer must procure that its Personnel waive their moral rights in any Feedback to the extent permitted by Law. Eirly may use Feedback for any purpose without compensation or restriction.
11.2A Results. Where the Customer orders Diagnostic Services through its own Ordering Practitioners, the Customer may use the Results it receives for its own purposes, and those of its Customers' End Users, without restriction from Eirly, subject to Privacy Law and the DPA. Where Eirly is the ordering party, Eirly keeps its own rights in that data. A Diagnostic Provider keeps its own rights in its reports. Nothing in this clause transfers or gives up any right of Eirly, or gives the Customer any right in the Platform or the API.
11.3 Protecting Intellectual Property Rights. Neither party may prejudice the other party's (or its licensors') Intellectual Property Rights, and, except as permitted under clause 12, must not use or contest the other party's Marks or apply for anything confusingly similar.
11.4 Unauthorised use. The Customer must notify Eirly immediately of any unauthorised access to or use of the API, any breach of Eirly's Intellectual Property Rights, or any third-party claim relating to them.
11.5 Infringement indemnity. Eirly indemnifies the Customer against any third-party Claim that the Platform or API, used in accordance with this Agreement, infringes that third party's Intellectual Property Rights. Eirly's liability under this clause is limited to the cap in clause 22.1, and the carve-out in clause 22.6(a) does not apply to it. The Customer must notify Eirly promptly of any such Claim, allow Eirly to control its defence and settlement, and provide reasonable assistance at Eirly's cost. This indemnity does not apply to the extent the Claim arises from the Customer's modification of the Platform or API, its combination with anything not supplied by Eirly, or its use in breach of this Agreement.
12. Marketing
12.1 Licence to Eirly. The Customer grants Eirly a revocable, non-exclusive, non-sublicensable, royalty-free licence to use the Customer's name, logo and other brand indicia, and any marketing material the Customer supplies, for case studies and joint marketing, in each case only with the Customer's prior approval of the specific use. The Customer is not required to submit its own marketing material to Eirly for approval.
12.2 Brand licence. Eirly grants the Customer a non-exclusive, non-transferable, revocable, royalty-free licence for the term of this Agreement to use the Marks of Eirly, including the Eirly Health and Bloody Good Tests names and logos, in the Customer's marketing and promotional material, website, application, and communications with its Customers' End Users, for the purpose of identifying that the Customer offers Diagnostic Services, or that those Diagnostic Services are facilitated or supplied by Eirly.
12.3 Conditions of brand use. When using the Marks of Eirly, the Customer must: (a) use each Mark only in a form Eirly makes available, without altering, distorting, recolouring, animating, cropping or combining it with another mark, and in accordance with any brand guidelines Eirly makes available from time to time; (b) not use the Marks in a way that states or implies that the Customer is Eirly, or that Eirly is the Customer's partner, agent or joint venturer beyond the arrangement in this Agreement, or that Eirly endorses or is clinically responsible for the Customer's own products, services or advice; (c) not make any representation inconsistent with clauses 3, 5 or 10, including any representation that a Channel Customer provides the clinical service; (d) not use the Marks in connection with material that breaches clause 10.2, or that is misleading, deceptive, unlawful, or likely to damage Eirly's reputation or that of the Marks; (e) not use any Mark, or anything confusingly similar, in its own business name, trading name, domain name, application name or social media handle, or as a trade mark of its own; (f) promptly correct or withdraw any use that Eirly reasonably objects to, on notice from Eirly; and (g) cease using the Marks within 30 days after this Agreement ends, other than incidental references in historical or archived material.
12.4 Diagnostic Provider and vendor marks: no automatic approval. The licence in clause 12.2 covers Eirly's own Marks only. It does not extend to the name, logo or other brand indicia of any Diagnostic Provider, Supply-Side Partner or other vendor supplying through the Marketplace, whether or not that provider fulfils the Customer's orders. Eirly does not sublicense any third-party mark and gives no approval by default.
The Customer must not name, identify or display the marks of any such provider, and must not state or imply a partnership, endorsement, affiliation or accreditation between the Customer and that provider, without Eirly's prior written approval. Eirly may withhold that approval, or condition it (including on the provider's own written consent and on that provider's brand requirements), at its discretion. A provider may decline to be publicly identified, and Eirly is not obliged to seek or obtain its consent.
The Customer may instead describe the arrangement generically, for example, that it partners with Eirly Health, and that Eirly fulfils Diagnostic Services through a network of accredited laboratories, imaging providers and other Diagnostic Providers, provided the description is accurate and complies with clauses 3, 5 and 10.
Notwithstanding this clause, the Customer may name a Diagnostic Provider for the purpose of fulfilling Diagnostic Services, including directing a Customers' End User to a specific collection centre. That permission is limited to naming the provider and stating factually where fulfilment occurs. Use of a provider's marks or logo, or anything stating or implying a partnership, endorsement or affiliation, requires that provider's consent, which Eirly will use reasonable endeavours to obtain but does not guarantee.
12.5 Ownership and goodwill. As between the parties, each party owns its own Marks, and all goodwill arising from the other party's use of them accrues to the owner. Nothing in this clause transfers any right, title or interest in a party's Marks. Eirly's use of the Customer's Marks requires the Customer's approval under clauses 12.1 and 12.6. Eirly may vary the permitted forms of its Marks, or revoke the licence in clause 12.2 in whole or in part, on written notice, acting reasonably.
12.6 Publicity. With the Customer's prior written consent, Eirly may identify the Customer as a customer of Eirly, and use the Customer's name and logo, in Eirly's customer lists and marketing materials, in accordance with the Customer's reasonable brand guidelines. The Customer may withdraw this permission on written notice.
13. Updates
13.1 Changes to the Platform. Eirly may update, modify, deprecate or replace any part of the Platform or API at any time, at its discretion and without the Customer's agreement. Where an update may adversely affect how the Customer's systems communicate with the API, Eirly will give reasonable prior notice and, for a change that is not backward compatible, at least 30 days' notice except where a shorter period is required for security, legal or regulatory reasons. Clause 19.1 does not apply to a change Eirly makes under this clause. Where a change under this clause is a Material Change for the Customer, clause 23.6 applies to it.
13.2 Beta features. A feature that Eirly marks as beta, preview or early access is provided as is, without the service level objectives in clause 16, and may change or end at any time.
14. Fees and payment
14.1 Fees. The Customer must pay the Fees for the Services. Fees are set out in the Price List or, for negotiated deals, in the applicable Order Form. Fees are quoted exclusive of GST.
14.2 Pricing is not set out in the body of this Agreement. The current Price List is available in the Platform when the Customer is signed in, on request, or in the applicable Order Form, and the version applicable at the time of a transaction applies to that transaction. Eirly may introduce, vary or retire pricing and fee models for new or existing Diagnostic Services, products, panels, billing types (including Medicare-billed items) and channels through the Price List without amending this Agreement, subject to clause 14.6. Where an Order Form sets a price, that price prevails over the Price List (clause 2.4).
14.3 Payment method. By using the Services the Customer authorises Eirly to charge its nominated payment method (a card or bank account on file, or the method set up in the Platform or stated in an Order Form) for all applicable Fees. The Customer warrants it is authorised to use that method. The Customer must keep a valid payment method on file while it holds an account and, after this Agreement ends, until every referral issued under its account has been used or has expired and every charge is paid. It must update the method within 14 days of Eirly's notice that it has failed or expired. If it does not, the amounts remain payable as a debt under clause 14.4, and, for a closed account, Eirly may cancel remaining unused referrals under clause 20.8(d).
14.4 Failed payments. If a payment fails, Eirly will notify the Customer and automatically retry up to 4 times over the following 14 Business Days. If payment is not resolved within that period, Eirly may suspend access to the Platform and API and recover outstanding amounts, including through a collection agency or law firm, with the Customer liable for reasonable recovery costs.
14.5 Refunds, credits and cancellations. (a) What the Order Price covers. The Order Price is the whole of what Eirly charges for a Product, including any service fee the Price List sets for the Customer's Plan. An Order Price may be made up of more than one component (for a commercial pathology order, for example, a base price together with a collection charge) and which components apply depends on what is ordered. Every amount charged is shown in the Platform before the order is placed. The only other amounts payable for the Services are the Platform Fee, any Usage Fee, and any fee set out in the Refund and Credit Policy or in clause 14.7. This paragraph does not affect Eirly's commission on a Customer markup under clause 14.10, which is a share of the Customer's own markup for collecting it and is not a charge on Eirly's price. Fees are non-refundable once a Diagnostic Service request has been processed, except as set out in this clause 14.5 and the Refund and Credit Policy. (b) The Refund and Credit Policy. The Refund and Credit Policy (the Policy) forms part of this Agreement and holds the operational detail and every amount, including any processing or administration fee. It may be changed on at least 30 days' written notice under clause 23.6. This clause sets the principles; where this clause and the Policy address the same matter, this clause governs the principle and the Policy governs the detail and the amount.
(c) Refund or credit depends on who paid. Where a Customers' End User paid Eirly directly (Send To), a permitted refund is made to that individual. Where the Customer paid (Buy For), a permitted refund is given as a credit to the Customer's account. A credit is non-transferable, cannot be redeemed for cash, and expires as set out in the Policy.
(d) Cancellation before anything is incurred. Where an order is cancelled before a specimen is collected or a kit is dispatched, and Eirly has incurred no cost from a Diagnostic Provider or Supply-Side Partner, the amount charged is refunded or credited in full, less any fee the Policy sets for the Customer's plan.
(e) Supply-Side Partner Products. Where a Product is supplied by a Diagnostic Provider or Supply-Side Partner under its own refund terms (including at-home test kits, imaging, at-home visits and other Marketplace services), those terms decide whether the cost of that Product is refundable and on what timeframe. Eirly passes through any refund it actually receives and cannot refund a cost the supplier does not refund. Eirly gives the Customer each supplier's current terms on request, and the Customer is responsible for checking them before ordering. At the Customer's request, Eirly will pursue the supplier's refund on the Customer's behalf and pass through to the Customer whatever it receives.
(f) Refund window. A request for a refund or credit must be made within the refund window stated in the Policy for that category of Product.
(g) Use after a refund. Where a refund or credit is given and the related referral, kit or Diagnostic Service is then used, the full amount becomes payable, and Eirly may reverse the refund or credit and charge it, together with the administration fee in the Policy, to the Customer's nominated payment method. The same applies where a Product is used more than once on a single paid order.
(h) Consumer rights, and the Customer's markup. Where a Customers' End User paid Eirly directly, that individual's rights under the Consumer Terms and the Australian Consumer Law apply and are assessed under those terms, not this clause; Eirly's direct cost of that cancellation is charged to the Customer. Any markup the Customer applies to its own Customers' End Users is a matter between the Customer and those individuals; where Eirly has collected such a markup and a refund is made, Eirly may recover the corresponding amount from the Customer.
(i) Refund of prepaid Platform Fees on a justified exit. Where the Customer ends a Plan, an Order Form or this Agreement because of Eirly's breach that Eirly has not remedied (clause 20.3), under clause 23.6, after objecting to a new sub-processor under the DPA, because of a Force Majeure Event affecting Eirly (clause 18.1), or where Eirly ends it for convenience under clause 20.2, Eirly refunds any Platform Fee paid in advance for the unused period, pro rata.
14.6 Changes to Fees. Eirly sets its own Fees, and this clause sets out how it may change them and what an Order Form can do to give the Customer more certainty.
(a) Notice. Eirly may change any of its Fees (the Platform Fee, any Usage Fee and any Order Price) on written notice, as follows. Eirly will change the Platform Fee and any Usage Fee no more than once in any six-month period, on at least 60 days' written notice. Eirly may change an Order Price on at least 30 days' written notice and, other than to pass on a change in what a Diagnostic Provider or Supply-Side Partner charges Eirly (which Eirly will evidence on request), no more than once in any six-month period. An Order Form may provide otherwise under paragraph (b).
(b) Where an Order Form or an annual Plan gives more. An Order Form may provide for a longer notice period, or may hold the Platform Fee and any Usage Fee at a stated amount for a stated period. Where it does, that longer notice or hold applies for that period and the Customer's corresponding minimum term applies with it. An annual Plan holds the Platform Fee and any Usage Fee for the 12 months paid in advance. At the end of those 12 months the Plan continues month to month at the then Price List price unless an Owner pays for another year; Eirly will offer that renewal at least 30 days before the year ends.
(c) What an Order Form cannot hold. A hold or a longer notice period cannot apply to an Order Price, which remains changeable on the notice in paragraph (a). An Order Price depends on what Eirly's Diagnostic Providers and Supply-Side Partners charge Eirly and on their terms with Eirly, which Eirly does not control. Eirly seeks longer notice from its own providers but cannot commit to passing on more notice than it receives. A hold under an annual Plan is subject to the same limit. Absent a hold, Fees agreed in an Order Form are fixed for that Order Form's minimum term unless the Order Form states otherwise.
(d) If the Customer does not accept a change under this clause, it may terminate on written notice before the change takes effect, and may do so even if an Order Form minimum term has not expired. Continued use after the change takes effect constitutes acceptance of it.
(e) The price applicable to an order is the price in effect when the order is placed; later changes apply only to future orders.
14.7 Approved providers, follow-up and additional-work fees. The Customer must direct collection and testing only to the Diagnostic Providers and collection points approved by Eirly and identified on the current referral or request form, or otherwise approved by Eirly in writing. Standard follow-up with approved Diagnostic Providers (including recollections and re-issuing referrals) is included in the Services. Where the Customer directs a specimen or order to a provider or collection point that is not approved, and Eirly must locate, chase or reconcile the resulting data or results, Eirly may charge the Customer an out-of-network fee at the fixed amount set out in the Price List, plus any charge the provider makes to Eirly in respect of that result, at cost; or at Eirly's then-current hourly rate where the work materially exceeds that fixed amount. The fee is billed monthly to the Customer's nominated payment method and the Customer may pass it on. No fee applies where the result reaches Eirly through the Customer's nominated secure fax address and is processed without manual intervention. More generally, where the Customer asks Eirly to perform work outside the standard, automated ordering and results flow, or where additional work arises from the Customer's error, off-system request, or non-compliance with this Agreement, Eirly may charge for that work at its then-current hourly rate, billed monthly. Standard use of the Services as designed is not chargeable under this clause. The out-of-network fee is not subject to the work-order requirement below: it applies whenever the circumstances described above arise, for every Customer. Before carrying out other chargeable work under this clause at an hourly rate, Eirly will obtain the Customer's written confirmation that the Customer requests the work and accepts the applicable rate. For work beyond a simple follow-up, Eirly will issue a work order setting out the scope, deliverable, timeframe and estimated cost, to be accepted in writing before the work starts; work outside an accepted work order is not chargeable, and Eirly will not expand its scope without the Customer's written agreement. The applicable rate is the then-current rate in the Price List. Eirly records the event and may waive a fee where reasonable. The Customer may dispute a fee in good faith, and Eirly will not treat a good-faith dispute as non-payment while it is being resolved. An Order Form may set different terms for enterprise Customers.
14.8 Chargebacks. A chargeback, reversal or dispute the Customer raises on its own payment does not relieve it of Fees due for a Diagnostic Service that has been processed. The parties will use good faith efforts to resolve any disputed payment amicably.
14.9 Billing.
(a) How Fees are charged. Fees are charged to the Customer's nominated payment method, either at the time of the order or by monthly direct debit, as set out in the Price List for the Customer's plan.
(b) Invoicing. Invoicing and credit terms are not available by default. Where a plan in the Price List provides for invoicing, an Order Form expressly provides for it, or Eirly agrees to it at its discretion, Fees are invoiced monthly in arrears and payable within 7 days of the date of the invoice, unless the applicable Order Form states a different period, and Eirly may require a direct debit authority, a backup payment card, or other security as a condition of those terms.
(c) Payment security. Eirly may require a direct debit authority and a backup payment card, neither of which may be removed while orders or charges are open (including after this Agreement ends, under clause 20.8), and may debit earlier or more frequently than monthly where unbilled charges exceed the threshold in the Price List.
(d) Failed payments. Where a payment fails, clause 14.4 applies and Eirly may revert the Customer to payment at the time of the order.
(e) Charging on delivery. Where an Order Form provides for charging when a Result is delivered, Eirly may require security and set a limit on unpaid charges.
(f) Insolvency. If the Customer becomes insolvent, ceases or threatens to cease business, or commits an act of insolvency, all amounts owing become immediately due and payable and Eirly may suspend or terminate immediately.
14.10 Permitted transactions and markups. The Customer may only order, sell, price or process through the Platform the Diagnostic Services and Products approved by Eirly. The Customer must not use the Platform or its payment processing for any other goods or services, or for anything unlawful, unapproved, or outside the scope of the Services. The Customer may apply a markup to any Product offered through the Marketplace. A markup may cover the Customer's own related service, such as reviewing results or a consultation, but must not be used to collect payment for a separate or unrelated product or service, or for anything the Customer could not lawfully sell, such as an unapproved therapeutic good. Eirly may refuse, hold or reverse a markup used for those purposes. No markup, co-payment or other amount may be applied, charged or collected in respect of a Diagnostic Service for which a Medicare benefit is claimed or assigned (clause 14.11). Where the Customer applies a markup on a Send To order, Eirly collects the marked-up amount from the individual, remits the markup to the Customer when the Result is delivered, and retains a commission on that markup at the rate set out in the Price List, being a charge for collecting and remitting it and not a charge on the price of the Diagnostic Service.
Disclosure and no inducement. The Customer must not allow any commercial arrangement with Eirly to influence the clinical appropriateness of the Diagnostic Services it orders, and must comply with any requirement imposed on it by its professional body, a regulator or Law in respect of inducements, financial interests, and disclosure to patients. Nothing Eirly offers under this Agreement, including any discount, markup facility or commercial structure, is intended as, or may be treated as, an inducement to order a Diagnostic Service.
On-supply. Where the Customer on-supplies a Diagnostic Service or Product to a Customers' End User in its own name, including where it applies a markup, the Customer is the supplier of that service or product to that individual for the purposes of the Australian Consumer Law. The Customer is responsible for insuring that activity, including its obligations as supplier and any contractual liability it assumes. The Customer warrants that everything it transacts through the Platform is lawful, legitimate, and within the approved scope. Eirly may, acting reasonably and with prior notice to the Customer, review, limit, decline, hold or refund any transaction that appears to be outside the approved scope, unlawful, or a misuse of the payment processing; may suspend under clause 4.4 or terminate under clause 20.3; and may report the matter as required by law or by its payment processor. Eirly may act without prior notice only where immediate action is required by Law, by a regulator, or by its payment processor, or where notice would prejudice the investigation of a suspected unlawful transaction. Where Eirly acts without prior notice it will notify the Customer promptly afterwards, with reasons.
14.11 Medicare requests. The Platform lets the Customer and its Ordering Practitioners create a request for a Diagnostic Service that may attract a Medicare benefit, and receive its Results. Eirly has no part in Medicare billing: it does not bill or claim from Medicare, is not the requesting party, and receives no part of a Medicare benefit. Whether a service or a patient is eligible for a Medicare benefit is decided by the Customer or its Ordering Practitioner, who is solely responsible for the accuracy and lawfulness of the request and for cooperating with any Medicare compliance or Professional Services Review process.
For a Medicare-billed service Eirly charges only the Platform Fee and any applicable Usage Fee, being a charge for the software, integration and data services Eirly performs in receiving, normalising, matching and delivering the Result. Eirly charges nothing for, and takes no share of, the Diagnostic Service itself. No markup, co-payment or other amount may be applied, charged or collected from an individual in respect of a Diagnostic Service for which a Medicare benefit is claimed or assigned, and the Customer must not use the Platform to collect any such amount.
15. Taxes
15.1 GST. All Fees and amounts under this Agreement are exclusive of GST. Where a taxable supply is made, the recipient must pay, in addition and against a valid tax invoice, the GST amount at the same time as the consideration. Where a party is indemnified or reimbursed, the amount is net of any input tax credit available. Terms in this clause have the meaning given in the A New Tax System (Goods and Services Tax) Act 1999 (Cth).
16. Support and service levels
16.1 Support. Eirly will provide reasonable-efforts support for the Platform and API, through the support arrangements described for the Customer's Plan.
16.2 Service level objectives. Eirly works towards the following objectives for the Platform and API:
(a) availability of 99.5% in each calendar month;
(b) making a Result available to the Customer through the Platform or API within 24 hours of Eirly receiving it from the Diagnostic Provider; and
(c) responding to a support request within 24 hours for a critical issue (meaning the Platform or API is unavailable, or Results cannot be received or delivered, but not an issue with a single Result), and within 3 Business Days for any other request.
These are objectives, not commitments or warranties. Eirly is a platform and provides reasonable-efforts support under clause 16.1. Eirly does not provide service credits or any other remedy for failing to meet an objective in this clause 16.2, and a failure to meet one is not of itself a breach of this Agreement. Committed service levels, and any remedy for missing them, apply only as set out in an Order Form under clause 16.4. Nothing in this clause reduces Eirly's obligation under clause 16.1, and nothing in it limits clause 22.7.
16.3 Exclusions and reclassification. The objectives in clause 16.2, and any committed service levels under clause 16.4, do not apply to an incident or performance issue:
(a) caused by factors outside Eirly's reasonable control, including a Force Majeure Event or an internet, connectivity or related problem beyond the demarcation point of Eirly's network;
(b) resulting from the acts or omissions of the Customer, a Customers' End User, a Diagnostic Provider, a Supply-Side Partner, or another supplier whose service Eirly relies on but does not control, other than Eirly's own Personnel and subcontractors;
(c) resulting from the Customer's or a third party's (other than Eirly's subcontractors') equipment, software or other technology;
(d) arising during a suspension under clause 4.4, or after this Agreement ends; or
(e) occurring during scheduled maintenance for which Eirly has given at least 48 hours' notice.
The objective in clause 16.2(b) does not apply to a Result that requires manual extraction because a Diagnostic Provider supplied it in a non-standard format, a Result received from a provider outside Eirly's approved networks, or a Result for a commercial Diagnostic Service held for clinical review under clause 5.5, for which the period runs from completion of that review.
Eirly may reclassify the severity of an incident where it is not reproducible or is no longer affecting the Customer, where a workaround is available that reduces its impact, or where the Customer is not providing the cooperation or access reasonably needed to resolve it.
16.4 Committed service levels. Any committed service levels (response and resolution targets, uptime commitments and associated remedies) apply only where, and as, set out in an Order Form. In the absence of an Order Form specifying service levels, no service-level commitment applies and clauses 16.1 to 16.3 govern.
17. Notices
17.1 Notices. A notice must be in writing and in English, and delivered to, posted to, or emailed to the recipient's address as set out at acceptance or as later notified. Eirly may give a notice to the Customer by email to the account email address of any Owner, and may also show it in the Platform. The Customer may give a notice to Eirly by email to support@eirly.health. A notice is taken to be received: if delivered, when delivered; if posted, on the 5th Business Day after posting (12th if to or from outside Australia); if emailed, on the first Business Day after despatch unless the sender receives a failure or out-of-office notice.
18. Force majeure
18.1 Force majeure. Neither party is liable for delay or failure to perform caused by a Force Majeure Event. The affected party must notify the other promptly. If the event continues for more than 6 months, either party may terminate on written notice.
19. Changes to specifications
19.1 Customer-requested changes. This clause applies only to a change to the API or the Services that the Customer requests. Eirly will respond to a request with the scope, cost and timeframe (Adjustments), and no Adjustment takes effect unless both parties agree in writing. This clause does not apply to changes Eirly makes to the Platform or API, which are governed by clause 13.1 alone. The Customer has no right to require, withhold agreement to, or delay a change Eirly makes under clause 13.1.
20. Term and termination
20.1 Term. This Agreement commences on the Commencement Date and continues indefinitely until terminated in accordance with this clause.
20.2 Termination for convenience. Either party may terminate this Agreement, or an Order Form, on 30 days' written notice. For the Customer, ending this Agreement means closing its organisation account. Where the Customer ends this Agreement during an annual Plan, no refund is due for the unused period except under clause 14.5(i). However, where an Order Form specifies a minimum term, neither party may terminate that Order Form, or this Agreement to the extent it applies to that Order Form, for convenience before the end of that minimum term. This does not affect termination under clause 20.3, termination on insolvency under clause 14.9, or the Customer's right to terminate under clause 23.6.
20.2A Cancelling a Plan. An Owner may cancel a paid Plan on 30 days' notice, in the Platform or by email to support@eirly.health. The cancellation takes effect at the end of the notice or, for an annual Plan, at the end of the year paid for, if later, and the Customer then moves to the Free Plan. Cancelling a Plan, or moving to the Free Plan, does not end this Agreement, which continues with the payment method on file.
20.3 Termination for cause. Either party may terminate this Agreement or an affected Order Form if the other party breaches a material provision and, having been given written notice describing the breach and the required remedy, fails to remedy it within a reasonable period of not less than 14 days.
Eirly may also terminate this Agreement or an affected Order Form immediately on written notice where it reasonably suspects fraud, misuse of the Platform or its payment processing, or the use of a false, invalid or unauthorised practitioner credential, or where the Customer commits a material breach that cannot be remedied, breaches clause 4.6, or, as a Practitioner Customer, no longer has an Ordering Practitioner with a current registration for the Diagnostic Services it requests.
20.4 Effect of termination. Termination does not release a party from accrued liabilities or prevent it from pursuing rights or remedies. The provisions that by their nature survive termination (including clauses 1, 2, 4.5, 4.7, 5.3, 5.4, 6.6, 8, 11, 12.3(g), 12.4, 12.5, 14 in respect of accrued amounts, 14.3, 14.7, 14.8 and 14.9(c) as clause 20.8 provides, 15, 17, 20.5, 20.6, 20.8, 21, 22, 23, 24 and 25, and the DPA) survive. Clause 4.6 survives for 24 months after this Agreement ends.
20.5 Data on termination. On termination, at the Customer's request made within 90 days (or the period in any applicable DPA, whichever is longer), Eirly will make available an export of the Customer's data in a structured, commonly used, machine-readable format within 7 days of the request, and will record the export as a transfer of the records it held for the Customer, after which Eirly may delete it. This is subject to Eirly's obligation under applicable Law to retain data, including health records, which must generally be retained for a minimum of 7 years from the date of last service and, for a patient who was a minor at the time of the service, until the patient turns 25. Eirly will continue to protect retained data in accordance with this Agreement for so long as it is retained. For so long as Eirly retains any Records under this clause, the Customer may request specific Records or Results, including in response to a patient, audit or regulatory request, and Eirly will provide them within 10 Business Days. Records and Results are provided as they stood at the termination date; Eirly is not obliged to provide subsequent updates. No charge applies to a request that arises from a Customers' End User's access or correction request, an audit, or a regulatory, AHPRA or coronial demand, or that is otherwise reasonable in scope. Eirly may charge at its hourly rate set out in the Price List only for a request that is materially in excess of the ordinary course, and will tell the Customer the expected charge before starting the work.
20.6 Protecting individuals on termination. On termination or suspension, Eirly may take reasonable steps to protect Customers' End Users with an order in progress, including continuing to deliver Results for specimens already collected, notifying affected individuals, and directing them to the Customer or to another source of care. Those steps are at Eirly's discretion and do not reduce the Customer's obligations under clause 5.3, which continue in respect of every Diagnostic Service requested before termination, including communicating Results and following them up.
20.7 Change of control. Eirly may terminate this Agreement or an Order Form on 30 days' written notice if the Customer undergoes a change of Control (as defined in the Corporations Act 2001 (Cth)) under which Control is acquired by a direct competitor of Eirly. A change of Control does not include a bona fide equity financing, the issue or conversion of a convertible instrument, or an internal reorganisation that does not change ultimate beneficial Control. Each party must notify the other of an actual change of its Control after it completes.
20.8 Orders outstanding when this Agreement ends. (a) Every order placed before this Agreement ends, including a referral used after it ends, stays under this Agreement. The Order Price, any fee under clause 14.7 (including the out-of-network fee and any provider's charge), any re-charge under clause 14.5(g) or 4.4, and any amount under clause 14.8 are payable whenever they arise. (b) The Customer's payment authority (clause 14.3) and the payment security in clause 14.9(c) continue until every referral issued under the Customer's account has been used or has expired and every charge is paid. (c) The Customer stays responsible for its Customers' End Users following Eirly's collection instructions (clause 14.7) for those referrals, and clause 20.6 continues to apply. (d) Where the Customer cannot be billed (no valid payment method after notice under clause 14.3, insolvency, or suspected fraud), Eirly may cancel an unused referral. Before it does, Eirly notifies the Customer and, where Eirly holds their contact details, the individual, telling them to see their practitioner. Eirly refunds or credits the cancelled referral under the Refund and Credit Policy. Cancelling never affects a specimen already collected or a Result owed.
21. Information rights
21.1 Information on request. On Eirly's reasonable request, the Customer must promptly provide: (a) its current privacy policy and customer terms relevant to the Diagnostic Services; (b) evidence of its consent mechanisms for data sharing with Eirly and Diagnostic Providers; and (c) other documentation demonstrating its compliance with data-protection obligations under this Agreement.
22. Liability
22.1 Liability cap. Subject to clauses 22.4, 22.5, 22.5A, 22.6 and 22.6A, each party's total cumulative liability arising out of or relating to this Agreement and the Services, whether in contract, tort or otherwise, will not exceed the total Fees paid by the Customer under the applicable Order Form (or, for self-serve customers, under this Agreement) during the 6 months preceding the event giving rise to the Claim. This cap does not apply to, and does not limit, the Customer's obligation to pay Fees, amounts for Diagnostic Services ordered, chargebacks, or Eirly's reasonable costs of recovering them. Those amounts are payable in full.
22.2 Proportionate reduction (mutual). Each indemnity given by a party under this Agreement or the DPA, including under clauses 11.5, 22.5 and 22.5A and any indemnity in an Order Form, is reduced proportionately to the extent that the Claim was caused or contributed to by the other party or its Personnel.
22.3 What Eirly is not responsible for. Subject to clauses 22.6 and 22.7, and except to the extent caused or contributed to by Eirly or its Personnel, Eirly is not liable for, and the Customer releases Eirly from, any liability arising from or connected with: (a) the clinical or analytical performance of a Diagnostic Service by a Diagnostic Provider; (b) a change to the availability or nature of a Diagnostic Service made in accordance with clause 3.2; (c) errors or inaccuracies in a Result as produced by a Diagnostic Provider; (d) the accuracy, completeness or timeliness of data or a Result that Eirly receives from a Diagnostic Provider, Medicare, the Customer or another third party, or a failure or delay by such a party in providing it to Eirly; or (e) the Customer's failure to obtain necessary consents or provide required privacy notices.
Nothing in this clause releases Eirly from liability for its own act or omission, including loss, corruption, mis-matching or mis-delivery of a Result within the Platform, a failure by Eirly to transmit a Result it has received, or anything Eirly does under clause 5.5. Where the Customer's loss arises from a Diagnostic Provider's performance, Eirly will, at the Customer's request and cost, and to the extent Eirly's agreement with that Diagnostic Provider permits, enforce its rights against that Diagnostic Provider for the Customer's benefit and account to the Customer for any amount recovered that is referable to the Customer's loss.
22.4 Consequential loss (mutual). To the maximum extent permitted by Law, neither party is liable to the other for any indirect or consequential loss, or for any loss of profit, revenue, anticipated savings, goodwill, business or opportunity, or for any loss or corruption of data beyond the reasonable cost of restoring it from the most recent backup, whether arising in contract, tort (including negligence), statute or otherwise, and whether or not the loss was foreseeable. The reasonable, documented costs of assessing, notifying and remediating a data breach caused by the other party are direct losses and are not excluded by this clause; they remain within the cap in clause 22.5.
22.5 Data and privacy indemnity (mutual). Each party (as indemnifying party) indemnifies the other party and its Personnel against any third-party Claim to the extent arising from the indemnifying party's breach of applicable data protection or privacy Laws in relation to Customers' End User data. Each party's total liability under this clause 22.5 is limited to the greater of (a) the cap in clause 22.1 and (b) the limit of the cyber and privacy liability insurance that party is required to hold under clause 23.7, where an Order Form states one. Where a party causes the breach, that amount may be applied to the reasonable direct costs of the other party's own assessment, notification and remediation. An Order Form may state a different amount for this clause. Liability under the DPA sits within the limits in this clause 22. Where an Order Form adds a data protection indemnity, liability under it is subject to the cap in this clause 22.5 unless the Order Form states otherwise, and it does not create a separate or additional cap. This clause 22.5 does not limit clause 22.5A, which governs the Customer's liability for a Claim that falls within both.
22.5A Customer indemnity. The Customer indemnifies Eirly and its Personnel against any third-party Claim, including a Claim by a Customers' End User or a regulator, to the extent it arises from: (a) a clinical decision, advice, or failure to act on a Result by the Customer or its Ordering Practitioners, where this Agreement makes that the Customer's responsibility (including under clauses 5.3, 5.4, 5.6 and 5.7); (b) the Customer's breach of clause 4.3, 4.6, 4.8 or 10; or (c) information, documents or other content that the Customer or its Personnel supplied without the rights, consents or authorisations this Agreement requires. This indemnity is reduced under clause 22.2 to the extent Eirly or its Personnel caused or contributed to the Claim. The cap in clause 22.1 does not apply to the Customer's liability under this clause, unless an Order Form states a cap. This clause does not limit clause 22.6.
22.6 Carve-outs from the cap. The cap in clause 22.1 does not apply to and does not limit: (a) a party's deliberate or reckless breach of clause 24 (Confidentiality) or clause 11 (Intellectual Property), or deliberate or reckless breach of clause 4.6 (no systematic extraction or replication); or (b) fraud, wilful misconduct, or liability for death or personal injury, including under an indemnity in respect of a third-party Claim for death or personal injury. Clause 22.4 does not exclude a party's loss of profit, revenue, goodwill or business caused by the other party's deliberate or reckless breach of clause 4.6, or by its use of the first party's Confidential Information or Intellectual Property Rights to build, operate or promote a competing product or service.
22.6A Confidentiality cap. Any other liability of a party for breach of clause 24 in respect of the other party's business Confidential Information is limited to twice the cap in clause 22.1.
22.7 Liability that cannot be limited. Nothing in this clause limits liability that cannot be limited under the Australian Consumer Law or other applicable Law.
23. General
23.1 Assignment. The Customer may not assign or otherwise deal with this Agreement without Eirly's prior written consent, such consent not to be unreasonably withheld or delayed. Eirly may assign, novate or transfer its rights and obligations to any entity within its company group, and the Customer consents to such transfer and agrees to sign any document reasonably required to give effect to it.
23.2 Relationship. Nothing in this Agreement creates a joint venture, agency, partnership or fiduciary relationship.
23.3 Governing law. This Agreement is governed by the laws of Queensland, Australia, and the parties submit to the exclusive jurisdiction of the courts of Queensland and the Federal Court of Australia, and the courts that hear appeals from them.
23.4 Severability. If a provision is void or unenforceable, it is severed and the remainder continues in force.
23.5 Counterparts / electronic acceptance. This Agreement may be accepted electronically and in counterparts, each of which is an original and together one instrument.
23.6 Variation. Eirly may vary this Agreement, including the DPA and the Refund and Credit Policy, on at least 30 days' written notice under clause 17. The notice states the date the variation takes effect and links the new text. Continued use of the Services after that date is acceptance of the variation. If a variation is a Material Change for the Customer, the Customer may tell Eirly before the variation takes effect that it does not accept it, and the parties will discuss it in good faith. If they have not agreed by the date the variation takes effect, the Customer may choose either: (a) to terminate this Agreement by notice, even within an Order Form minimum term or an annual Plan, and clause 14.5(i) applies; or (b) where it has paid for an annual Plan in advance or is within an Order Form minimum term, to stay on the unvaried terms until the end of that paid period or minimum term. Changes to Fees follow clause 14.6. An Order Form signed by both parties is varied only in writing signed by both parties.
23.7 Insurance. The Customer must hold the insurance required by Law or by its registration for its business and profession, including professional indemnity insurance where it provides Medical Services, and must ensure each of its Ordering Practitioners holds the insurance their registration requires. Any other insurance a party must hold, and its level, is as stated in an Order Form. On reasonable request, a party will provide a certificate of currency for insurance this clause or an Order Form requires it to hold.
23.8 No waiver. A failure or delay in exercising a right under this Agreement is not a waiver of it. A waiver is effective only in writing, and only for the instance it describes.
24. Confidentiality
24.1 Confidentiality. Each party must not disclose the other's Confidential Information except: (a) to its controlled or controlling entities and their Personnel and professional advisors, under equivalent confidentiality obligations and on a need-to-know basis; (b) in enforcing this Agreement or in related proceedings; or (c) as required by Law or a binding order, in which case it gives the other party prior notice where the Law allows and discloses only what is required.
24.2 Financing and sale. Either party may disclose Confidential Information as necessary in connection with a capital raising, financing, or a merger, sale, change of control or reorganisation of its business, provided the recipient is under confidentiality obligations on substantially similar terms, and the disclosing party uses reasonable efforts to minimise the disclosure and gives prior notice.
24.3 Use limited to Permitted Purpose. Each party must use the other's Confidential Information only to the extent necessary to perform its obligations or exercise its rights under this Agreement (the Permitted Purpose), and not for any other purpose.
24.4 Remedies. Each party acknowledges that damages alone may not be an adequate remedy for a breach of clause 4.3, 4.6, 11 or 24, and that the other party may seek an injunction, specific performance, an account of the profits made from the breach, or other equitable relief, in addition to any other remedy.
25. Dispute resolution
25.1 Negotiation. If a dispute arises, a party may notify the other, and each party's nominated representatives must attempt in good faith to resolve it. If unresolved within 7 days, it is escalated to a Senior Executive (Managing Director, CEO or COO) of each party.
25.2 Further steps. If unresolved within 14 days of escalation, either party may pursue any lawful dispute resolution or legal and equitable remedies.
25.3 Urgent relief. Nothing in this clause prevents a party from seeking urgent injunctive relief.